Proteomics Intl Labs Ltd has released a press release.
Response to ASX Price Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- US Medicare sets reimbursement price for PromarkerD DKD test
- OxiDx test correlates with superior racehorse performance
- Proteomics International receives $2.2m in R&D tax incentive
- PromarkerEndo test for endometriosis receives $0.5m grant
- Collaboration expanded to advance Endometriosis blood test
Later from Proteomics International Laboratories
- PromarkerD predicts risk of DKD in Aboriginal Australians
- US patent secured for PromarkerEso diagnostic test for EAC
- Proteomics US lab CAP accredited - extends precision Dx lab
- Appointment of CEO and Managing Director
- Canadian patent secured for PromarkerEso test for EAC
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories